Abstract
Mutations in the gene encoding the phosphodiesterase 6 alpha subunit (PDE6A) account for 3–4% of autosomal recessive retinitis pigmentosa (RP), and currently no treatment is available. There are four animal models for PDE6A-RP: a dog with a frameshift truncating mutation (p.Asn616ThrfsTer39) and three mouse models with missense mutations (Val685Met, Asp562Trp, and Asp670Gly) showing a range of phenotype severities. Initial proof-of-concept gene augmentation studies in the Asp670Gly mouse model and dog model used a subretinally delivered adeno-associated virus serotype 8 with a 733 tyrosine capsid mutation delivering species-specific Pde6a cDNAs. These restored some rod-mediated function and preserved retinal structure. Subsequently, a translatable vector (AAV8 with a human rhodopsin promoter and human PDE6A cDNA) was tested in the dog and the Asp670Gly mouse model. In the dog, there was restoration of rod function, a robust rod-mediated ERG, and introduction of dim-light vision. Treatment improved morphology of the photoreceptor layer, and the retina was preserved in the treated region. In the Asp670Gly mouse, therapy also preserved photoreceptors with cone survival being reflected by maintenance of cone-mediated ERG responses. These studies are an important step toward a translatable therapy for PDE6A-RP.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arango-Gonzalez B, Trifunovic D, Sahaboglu A et al (2014) Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration. PLoS One 9:e112142
Bocquet B, Marzouka NA, Hebrard M et al (2013) Homozygosity mapping in autosomal recessive retinitis pigmentosa families detects novel mutations. Mol Vis 19:2487–2500
Corton M, Blanco MJ, Torres M et al (2010) Identification of a novel mutation in the human PDE6A gene in autosomal recessive retinitis pigmentosa: homology with the nmf28/nmf28 mice model. Clin Genet 78:495–498
Dryja TP, Rucinski DE, Chen SH et al (1999) Frequency of mutations in the gene encoding the alpha subunit of rod cGMP-phosphodiesterase in autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci 40:1859–1865
Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368:1795–1809
Huang SH, Pittler SJ, Huang X et al (1995) Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase. Nat Genet 11:468–471
Khan SY, Ali S, Naeem MA et al (2015) Splice-site mutations identified in PDE6A responsible for retinitis pigmentosa in consanguineous Pakistani families. Mol Vis 21:871–882
Mowat FM, Occelli LM, Bartoe JT et al (2017) Gene therapy in a large animal model of PDE6A-retinitis pigmentosa. Front Neurosci 11:342
Nair P, Hamzeh AR, Malik EM et al (2017) Novel PDE6A mutation in an Emirati patient with retinitis pigmentosa. Oman J Ophthalmol 10:228–231
Occelli LM, Schon C, Seeliger MW et al (2017) Gene supplementation rescues rod function and preserves photoreceptor and retinal morphology in dogs, leading the way towards treating human PDE6A-retinitis pigmentosa. Hum Gene Ther 28:1189–1201
Petersen-Jones SM, Entz DD, Sargan DR (1999) cGMP phosphodiesterase-α mutation causes progressive retinal atrophy in the Cardigan Welsh corgi dog. Invest Ophthalmol Vis Sci 40:1637–1644
Riazuddin SA, Zulfiqar F, Zhang Q et al (2006) Mutations in the gene encoding the alpha-subunit of rod phosphodiesterase in consanguineous Pakistani families. Mol Vis 12:1283–1291
Sakamoto K, McCluskey M, Wensel TG et al (2009) New mouse models for recessive retinitis pigmentosa caused by mutations in the Pde6a gene. Hum Mol Genet 18:178–192
Saqib MA, Nikopoulos K, Ullah E et al (2015) Homozygosity mapping reveals novel and known mutations in Pakistani families with inherited retinal dystrophies. Sci Rep 5:9965
Schon C, Sothilingam V, Muhlfriedel R et al (2017) Gene therapy successfully delays degeneration in a mouse model of PDE6A-linked retinitis pigmentosa (RP 43). Hum Gene Ther 28:1180–1188
Sothilingam V, Garcia Garrido M, Jiao K et al (2015) Retinitis pigmentosa: impact of different Pde6a point mutations on the disease phenotype. Hum Mol Genet 24:5486–5499
Takahashi VKL, Takiuti JT, Jauregui R et al (2018) Structural disease progression in PDE6-associated autosomal recessive retinitis pigmentosa. Ophthalmic Genet 39:610–614
Tsang SH, Tsui I, Chou CL et al (2008) A novel mutation and phenotypes in phosphodiesterase 6 deficiency. Am J Ophthalmol 146:780–788
Tuntivanich N, Pittler SJ, Fischer AJ et al (2009) Characterization of a canine model of autosomal recessive retinitis pigmentosa due to a PDE6A mutation. Invest Ophthalmol Vis Sci 50:801–813
Ullah I, Kabir F, Gottsch CB et al (2016) Mutations in phosphodiesterase 6 identified in familial cases of retinitis pigmentosa. Hum Genome Var 3:16036
Wert KJ, Sancho-Pelluz J, Tsang SH (2014) Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa. Hum Mol Genet 23:514–523
Wert KJ, Davis RJ, Sancho-Pelluz J et al (2013) Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa. Hum Mol Genet 22:558–567
Zhang S, Li J, Li S et al (2018) Targeted next-generation sequencing reveals that a compound heterozygous mutation in phosphodiesterase 6a gene leads to retinitis pigmentosa in a Chinese family. Ophthalmic Genet 39:487–491
Acknowledgments
RD-Cure consortium. This work was supported by Tistou and Charlotte Kerstan Stiftung and the Myers Dunlap Endowment for Canine Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this paper
Cite this paper
Petersen-Jones, S.M., Occelli, L.M., Biel, M., Michalakis, S. (2019). Advancing Gene Therapy for PDE6A Retinitis Pigmentosa. In: Bowes Rickman, C., Grimm, C., Anderson, R., Ash, J., LaVail, M., Hollyfield, J. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 1185. Springer, Cham. https://doi.org/10.1007/978-3-030-27378-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-27378-1_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-27377-4
Online ISBN: 978-3-030-27378-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)